Background: Since the Zika virus epidemic in the Americas began in 2015, Zika virus
| INTRODUC TI ON
Zika virus (ZIKV) was first discovered in 1947 in the Zika Forest of Uganda, with transmission reported over subsequent decades from other countries in Africa, Asia, and the Pacific. 1 ucts, and mother-to-child transmission (MTCT) in utero and perinatally. [8] [9] [10] However, limited information exists regarding the potential transmission risk associated with breast feeding and human milk.
The health benefits of breast feeding are well known and widely recognized. [11] [12] [13] In the United States, both the American Academy of Pediatrics and the American Academy of Family Physicians recommend that infants exclusively breast feed for the first 6 months of life and continue breast feeding until at least 1 year of age, or as long thereafter as mutually desired by mother and child. 11, 12 Among infants born in the United States, 81% initiate breast feeding, 52%
continue some breast feeding until at least 6 months of age (22% exclusively breast feed), and 31% breast feed until at least 1 year of age. 13 Given the maternal and child health advantages associated with breast feeding, most women are encouraged to breast feed.
However, in North America and other regions where safe and affordable replacement feeding is available, mothers with infections such as human immunodeficiency virus type 1 or Mycobacterium tuberculosis are discouraged from breast feeding. 11 Based on the limited data available regarding the potential infectivity of human milk, the WHO determined the benefits of breast feeding for the infant and mother outweigh any potential risk of ZIKV transmission through breast milk, and recommended that mothers with possible or confirmed ZIKV infection or exposure continue to breast feed. 14 However, because data about long-term outcomes associated with ZIKV infection in infants and young children are limited, it is important to elucidate any evidence of human milk transmission of ZIKV.
We conducted a systematic literature review to summarize the currently available evidence about the presence of flaviviruses in human milk and the risk of flavivirus transmission from mother to child through human milk as well as vertical transmission through nonhuman (animal) milk, specifically focusing on seven flaviviruses:
ZIKV, JEV, TBEV, POWV, WNV, DENV, and YFV. Our objectives were to assess studies regarding the presence and transmission of flaviviruses through human milk, and to evaluate animal studies regarding flavivirus transmission through milk.
| ME THODS

| Search strategy
A systematic review was conducted using Medline (OVID), Embase 
| Study selection and eligibility criteria
One author (TM) performed the database search on June 12, 2017. were maintained in an electronic library using EndNote software.
| Data synthesis
Included articles were reviewed for information of interest, and information was abstracted by two authors (TM, TW) using standardized abstraction forms developed for this review. A third author (LH) independently evaluated all studies and abstraction forms and resolved any disagreement on abstraction. Findings tables were constructed for each objective, stratified by individual flaviviruses and evidence of detection or transmission.
| RE SULTS
Database searches yielded 915 results, and two further articles were identified through manual searches of the reference sections of articles meeting inclusion criteria ( Figure 1 ). Of these 917 articles, based on screened titles and abstracts, 829 were either duplicates of the same article (n = 287) or unrelated to flavivirus transmission through human or animal milk (n = 542). The remaining 88 articles were screened, and 24 were excluded due to not meeting the inclusion criteria for language (n = 13) or document type (n = 11). The 64 remaining publications were assessed for eligibility. Of these, 17
descriptive studies were included in the findings tables; 47 articles were excluded as they described transmission of passive immunity through maternal antibodies (n = 13) or were secondary sources citing included studies (n = 34). Meta-analyses were not conducted because of limited data and heterogeneity of study designs.
| Detection of flaviviruses in human milk
Ten studies were identified that described detection of flavivirus genomic material (ZIKV, DENV, and WNV) in human milk (Table 1) .
Five articles (three case reports and two case series) described six cases in which ZIKV ribonucleic acid (RNA) was detected in human milk, including four in which ZIKV was cultured. [15] [16] [17] [18] [19] In one case series (n = 2), reverse-transcription polymerase chain reaction toms. 17 Finally, in a case report, ZIKV RNA was found in colostrum at 14 days and milk samples at 23 and 32 days after onset, and infectious ZIKV particles were found on culturing the day 14 colostrum sample and the day 32 milk sample. 19 DENV RNA was detected in milk samples from 10 women in two studies (one case report and one case series), including culturable virus in a sample from one woman. 20, 21 In the case report, DENV RNA was detected by RT-PCR in milk samples collected on days six and eight after the woman's symptom onset, with infectious virus particles detected at both time points. 20 The case series (n = 12) described DENV RNA detection in nine (75%) cases, with the longest observed period of detection being 14 days after maternal illness onset. 21 All DENV RNA positive samples were assessed for infectivity but were negative in cell culture. 21 Three studies (one case report and two cross-sectional studies)
described confirmed or possible detection of WNV RNA in human milk or colostrum. [22] [23] [24] WNV RNA was detected in human milk in one case, in colostrum in two cases, and there was an equivocal result in milk in one case; none of the studies demonstrated infectious virus particles. [22] [23] [24] In the case report, a milk sample tested at 6 days after maternal illness onset was positive for WNV RNA, but a subsequent sample collected on day 15 after onset was WNV PCRnegative; virus was not culturable. 22 In one cross-sectional study, WNV RNA was detected in colostrum samples from two women 50
and 70 days after maternal illness onset, but was not detected on testing 30 colostrum samples and 13 mature human milk samples from 43 other women infected with WNV during pregnancy. 23 Virus 
| Human milk transmission of flaviviruses
We identified nine studies (six case reports and three case series)
that addressed potential transmission of ZIKV, DENV, WNV, and YFV through human milk (Table 2) . Potential ZIKV transmission was described in three cases from two studies (one case report and one case series), although other modes of transmission were considered more likely for two cases. 15, 18 All of the women in these reports were symptomatic, and serum, saliva, and/or urine samples were ZIKV PCR-positive. 15, 18 All infants were ZIKV PCR-positive, but only one became symptomatic. 15, 18 In one case, both the viral genome isolated from milk and that found in the infant were shown to be 99% identical when sequenced. 18 Infection in mother-infant pairs was identified within the first week postpartum for two cases, 15 and at 5 months postpartum for the third. 18 Based on the timing of infant illness and/or positive test results, one case was considered possibly related to breast milk transmission, 18 and the remaining two cases were considered more likely to be perinatal infections. 15 Vectorborne transmission could not be excluded for two cases. Milk-borne transmission could not be confirmed in any of these cases. 15, 18 Two studies (one case report and one case series) reported possible DENV transmission through human milk in two cases. 20, 21 In the case report, DENV was detected in both mother and infant by RT-PCR. 20 Cord blood was negative for DENV by RT-PCR; however, perinatal transmission could not be ruled out. 20 In the other study, maternal onset was 2 days after delivery and infant onset was 5 days later. 21 A cord blood specimen was negative for DENV RNA, but perinatal and vector-borne transmission could not be excluded.
Two studies (one case report and one case series) described four cases of probable, possible, or potential human milk transmission of WNV. 22, 23 In the case report, the mother received a transfusion of blood products the day after delivery from the same donor who provided a donation that had resulted in WNV transmission after transfusion into a liver transplant patient. 22 Maternal symptoms began shortly after the transfusion, and the infant, though asymptomatic, tested positive for WNV-specific IgM about 2 weeks later, suggesting probable transmission by breast feeding. In a case series of mother-infant pairs, one breast feeding infant became ill at 8 months of age and was WNV IgM-positive. 23 The mother did not become ill until 1 month later, with IgM detected by serology. 23 The time-order of symptom onset of mother and child suggests vector-borne transmission was most likely. In two other cases, both women became symptomatic about 1 week antepartum and tested positive by serology. 23 One infant was born with a maculopapular rash and was WNV IgM-positive when tested at 2 months after birth. The other infant became symptomatic at 16 days after maternal onset (10 days after birth) and was WNV IgM-positive in both serum and cerebrospinal fluid (CSF); however, cord blood specimens were negative for WNV antibodies by serology. 23 The timing of maternal and infant symptom onset makes exclusion of perinatal transmission difficult in both cases, and vector-borne transmission could not be ruled out.
Three studies (all case reports) described confirmed or probable transmission of the vaccine strain of YFV through breasfteeding. [25] [26] [27] In the first case report, the mother received yellow fever vaccine 15 days after delivery, and had symptoms of headache, malaise, and fever at 20-22 days postpartum. 25 The 
| Animal milk transmission of flaviviruses
Possible vertical transmission of DENV, POWV, and WNV through animal milk was evaluated in four studies (Table 3 ). In the DENV study, six lactating hamsters underwent intraperitoneal inoculation, after which 32 suckling hamsters were allowed to nurse without interference for the subsequent 6 days. 28 Of the 32 subjects, four were determined to be DENV-positive. 28 In the POWV study, a lactating goat underwent intramuscular inoculation at 74 days postpartum and was subsequently allowed to nurse without restriction. 29 The kid remained asymptomatic, but both the mother and the kid were serologically positive for POWV neutralizing antibody. Milk samples were positive for both POWV and POWV-specific neutralizing antibody. 28 In a WNV study of mice, inoculation of the foster mother mice occurred prior to initiation of nursing in a subset of animal subjects. 30 Subsequently, brain tissue samples from five (17%) of 29 of the suckling mice were WNV PCR-positive, of which four (80%) were infectious. 30 In a different WNV study in hamsters, three mother hamsters underwent intraperitoneal inoculations postpartum and nursed 18
offspring. 31 Thirteen (72%) of 18 offspring had symptoms referable to the central nervous system and presence of WNV was confirmed. DENV, 20, 21 WNV, 22, 23 and ZIKV, [15] [16] [17] [18] [19] and was found to be potentially infectious in five of 20 cases (4 ZIKV, 1 DENV). [16] [17] [18] [19] [20] For ZIKV specifically, infectious virus was detected as late as 32 days post-onset of maternal illness. 19 Of the 12 reported cases of potential postnatal MTCT of the selected flaviviruses in humans, 15, 18, [20] [21] [22] [23] [25] [26] [27] nonbreast feeding-related routes of transmission could not be ruled out in all but one case involving vaccine strain YFV. 25 In our review of animal studies, we found evidence of milk-related transmission of three flaviviruses (DENV, POWV, WNV). [28] [29] [30] [31] The studies published to date are limited to individual case reports, case series, and crosssectional studies with small study populations. The small number of cases reported prohibits any determination of the actual risk of transmission associated with human milk. The small number of published studies meeting our eligibility criteria coupled with the lowquality evidence limits generalizability and hindered our ability to make strong conclusions or to conduct meta-analyses.
| Interpretation
The limitations of currently published studies and the difficulty in determining specific route of transmission in areas with mosquitoborne transmission of flaviviruses hinder our ability to make definite conclusions about the transmission of flaviviruses through milk.
While flavivirus genomic material may be detected in human milk, it is unknown how often the virus is replication-competent and/or of sufficient quantity to be infectious. In some of the included studies, the presence of virus-specific IgM and/or IgG in human milk was detected. [22] [23] [24] However, the implications of IgG or IgM presence in human milk are unclear, and these antibodies may confer passive immunity to the infant. Despite animal studies demonstrating the potential for transmission through milk, [28] [29] [30] [31] concerns remain as to whether the results of animal studies can predict human transmission and exposure. 33, 34 Many of the human observational studies involved maternal exposure during the perinatal period, and, in several case reports, the timing of MTCT could not be definitively determined, making confirmation of transmission through human milk (vs perinatal transmission) infeasible. 15, 18, 20, 21, 23 Further, in endemic areas, it is challenging to eliminate the possibility of mosquito vector transmission. 15, 16, [19] [20] [21] [25] [26] [27] Though closely related to the other selected viruses, ZIKV demonstrates distinct viral behavior, [6] [7] [8] [9] [10] 
| Strengths of the study
This review adds to the knowledge previously gathered by Colt et al 32 regarding possible ZIKV transmission through human milk, contributing additional ZIKV data and including information on possible transmission of other flaviviruses through human milk.
We included seven flaviviruses and both human and animal studies in our review, whereas Cole et al focused solely on ZIKV in humans. Despite including more viruses, our findings were similar to those of Cole et al, namely that there is limited evidence of vertical transmission of these viruses through milk but current data is inadequate to draw definitive conclusions.
| Limitations
Despite the value added by our review, several limitations exist.
Although we included a wide range of search terms, used several well-known databases, and searched references and citations of included studies, we may have missed some relevant studies. Our use of the search term 'human milk' may have increased the sensitivity of the search strategy for human studies relative to animal studies. Further, our review included only papers published in English, Spanish, or Portuguese languages, and excluded conference abstracts. As with any systematic review, publication bias is also possible, especially if studies are unpublished because of negative findings.
| CON CLUS IONS
Although evidence shows that flaviviruses can occasionally be present in human milk, there is very limited evidence of risk of flavivirus transmission through human milk to infants. For ZIKV specifically, the World Health Organization recommends that mothers with possible or confirmed ZIKV infection or exposure continue to breast feed as the health advantages of breast feeding are considered greater than the potential risk of transmission. 14 Should postnatal ZIKV infection in infancy and early childhood be causally linked to adverse health or developmental outcomes, more rigorous studies will be necessary to determine the level of risk and develop updated recommendations.
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